Report overview
Diabetes mellitus (DM), commonly known as diabetes, is a group of metabolic disorders characterized by high blood sugar levels over a prolonged period.
There are two predominant types of diabetes. Type 1 diabetes patients are typically diagnosed in childhood, and their bodies are not able to produce insulin. Type 1 accounts for less than 10% of diabetes patients, but the smaller population doesn't equate to minimal revenues. Synthetic insulin, the go-to treatment for type 1 diabetes, can also be prescribed to type 2 diabetes patients not responding to other treatments.
Type 2 diabetes is more common and differs from type 1 because the body produces insulin but isn't able to process it correctly. Patients are typically diagnosed over the age of 30, there tends to be a genetic predisposition, and obesity is closely related to this type.
This report aims to provide a comprehensive presentation of the global market for Diabetes Mellitus Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Diabetes Mellitus Treatment. This report contains market size and forecasts of Diabetes Mellitus Treatment in global, including the following market information:
Global Diabetes Mellitus Treatment Market Revenue, 2018-2023, 2024-2032, ($ millions)
Global top five companies in 2022 (%)
The global Diabetes Mellitus Treatment market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Type 1 Diabetes Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Diabetes Mellitus Treatment include Novo Nordisk, Sanofi, MannKind, Bristol-Myers Squibb and AstraZeneca, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Diabetes Mellitus Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Diabetes Mellitus Treatment Market, by Type, 2018-2023, 2024-2032 ($ millions)
Global Diabetes Mellitus Treatment Market Segment Percentages, by Type, 2022 (%)
Type 1 Diabetes
Type 2 Diabetes
Global Diabetes Mellitus Treatment Market, by Application, 2018-2023, 2024-2032 ($ millions)
Global Diabetes Mellitus Treatment Market Segment Percentages, by Application, 2022 (%)
Children
Adults
The Old
Global Diabetes Mellitus Treatment Market, By Region and Country, 2018-2023, 2024-2032 ($ Millions)
Global Diabetes Mellitus Treatment Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Diabetes Mellitus Treatment revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Diabetes Mellitus Treatment revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Novo Nordisk
Sanofi
MannKind
Bristol-Myers Squibb
AstraZeneca
Outline of Major Chapters:
Chapter 1: Introduces the definition of Diabetes Mellitus Treatment, market overview.
Chapter 2: Global Diabetes Mellitus Treatment market size in revenue.
Chapter 3: Detailed analysis of Diabetes Mellitus Treatment company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Diabetes Mellitus Treatment in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
